Mei Shi Selected Research

MicroRNAs (MicroRNA)

1/2019	Role and mechanism of miR-4778-3p and its targets NR2C2 and Med19 in cervical cancer radioresistance.
5/2014	MiR-489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mei Shi Research Topics

Disease

26	Neoplasms (Cancer) 09/2023 - 01/2002
17	Nasopharyngeal Carcinoma 01/2023 - 01/2012
16	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2023 - 02/2011
12	Infections 01/2020 - 01/2005
11	Breast Neoplasms (Breast Cancer) 12/2022 - 02/2010
9	Neurosyphilis (General Paresis of the Insane) 04/2024 - 01/2014
9	Lymphoma (Lymphomas) 01/2023 - 01/2018
7	Syphilis 05/2024 - 01/2014
7	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021 - 04/2015
6	Neoplasm Metastasis (Metastasis) 07/2021 - 10/2016
5	Esophageal Neoplasms (Esophageal Cancer) 03/2024 - 03/2017
5	Neutropenia 03/2023 - 01/2017
4	Esophageal Squamous Cell Carcinoma 03/2024 - 01/2017
4	Triple Negative Breast Neoplasms 02/2022 - 08/2011
4	Carcinoma (Carcinomatosis) 01/2018 - 01/2013
3	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2021 - 01/2014
3	Proteinuria 01/2021 - 01/2013
3	Hepatocellular Carcinoma (Hepatoma) 04/2013 - 02/2008
2	Brain Neoplasms (Brain Tumor) 03/2024 - 01/2002
2	Dyslipidemias (Dyslipidemia) 01/2023 - 01/2022
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 07/2022 - 01/2022
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 11/2021
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2020
2	secondary Syphilis 11/2021 - 05/2018
2	primary Syphilis 11/2021 - 05/2018
2	Latent Syphilis 11/2021 - 05/2018
2	Extranodal NK-T-Cell Lymphoma 01/2021 - 10/2018
2	Anemia 01/2019 - 01/2012
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2018 - 10/2013
2	Wounds and Injuries (Trauma) 07/2017 - 02/2008
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2016 - 11/2015
2	Squamous Cell Carcinoma of Head and Neck 08/2015 - 01/2013
2	Glomerulonephritis 01/2014 - 01/2013
2	Virus Diseases (Viral Diseases) 07/2013 - 12/2010
2	Hypoxia (Hypoxemia) 02/2011 - 01/2007
1	Headache (Headaches) 05/2024
1	Fatigue 05/2024
1	Syndrome (Syndromes) 05/2024
1	Pain (Aches) 05/2024
1	Plague (Bubonic Plague) 05/2024
1	Pruritus (Itching) 05/2024
1	Esophageal Fistula 03/2024
1	Male Infertility (Male Sterility) 12/2023
1	Liver Neoplasms (Liver Cancer) 08/2023

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2007
5	AnthracyclinesIBA 01/2023 - 12/2018
5	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 08/2015
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2005
4	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2014
4	CytokinesIBA 01/2021 - 07/2013
3	Gemcitabine FDA Link 01/2022 - 01/2019
3	TabletsIBA 01/2018 - 01/2013
3	Interleukin-2 (IL2)IBA 12/2014 - 07/2013
3	Transcription Factors (Transcription Factor)IBA 12/2014 - 01/2007
3	Interleukin-10 (Interleukin 10)IBA 06/2014 - 11/2012
3	PeptaibolsIBA 05/2014 - 02/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2013 - 01/2007
3	SurvivinIBA 02/2011 - 01/2007
2	Penicillin G (Benzylpenicillin)FDA LinkGeneric 05/2024 - 01/2017
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 05/2024 - 01/2017
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2023 - 01/2023
2	4-iodobenzenesulfonamideIBA 01/2022 - 12/2019
2	C-PeptideIBA 01/2022 - 11/2021
2	Treponema pallidum 47-kDa immunogenIBA 11/2021 - 05/2018
2	Messenger RNA (mRNA)IBA 01/2021 - 02/2011
2	HMGB1 Protein (HMG1)IBA 01/2020 - 01/2020
2	Sincalide FDA Link 01/2020 - 02/2018
2	CateninsIBA 01/2020 - 03/2012
2	Immunoglobulin G (IgG)IBA 11/2019 - 12/2013
2	PlatinumIBA 01/2019 - 08/2015
2	MicroRNAs (MicroRNA)IBA 01/2019 - 05/2014
2	LuciferasesIBA 01/2019 - 02/2018
2	Asparaginase (Elspar)FDA Link 10/2018 - 04/2015
2	Interleukin-17 (Interleukin 17)IBA 06/2015 - 01/2014
2	Antiviral Agents (Antivirals)IBA 01/2015 - 01/2013
2	Interleukin-12 (IL 12)IBA 12/2014 - 06/2014
2	Interleukin-6 (Interleukin 6)IBA 12/2014 - 06/2014
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2014 - 03/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2014 - 03/2014
2	Interleukin-4 (Interleukin 4)IBA 07/2013 - 11/2012
2	Peptide Initiation Factors (Initiation Factor)IBA 07/2012 - 02/2011
2	Eukaryotic Initiation Factor-4EIBA 07/2012 - 02/2011
2	Hormones (Hormone)IBA 08/2011 - 05/2003
1	Penicillins (Penicillin)FDA Link 05/2024
1	Plasma GasesIBA 12/2023

Therapy/Procedure

44	Radiotherapy 03/2024 - 01/2007
17	Drug Therapy (Chemotherapy) 03/2023 - 08/2011
15	Chemoradiotherapy 03/2023 - 01/2013
14	Therapeutics 04/2024 - 01/2005
10	Induction Chemotherapy 01/2023 - 01/2017
7	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 03/2024 - 01/2012
4	Mastectomy (Mammectomy) 12/2022 - 08/2011
4	Brachytherapy 01/2018 - 09/2011
3	Renal Dialysis (Hemodialysis) 05/2024 - 01/2015
3	Aftercare (After-Treatment) 11/2021 - 01/2002
3	Adjuvant Chemotherapy 06/2021 - 08/2011
3	Neoadjuvant Therapy 01/2021 - 11/2015
2	Immunotherapy 08/2023 - 01/2022
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2013 - 09/2011
1	Re-Irradiation 07/2023